Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Inoviq Ltd Appoints Dr. Emma Ball As Chief Commercial Officer

PRIVATEMar 16, 2025•over 1 year ago

Position

Chief Commercial Officer

Company

Inoviq Ltd

Emma Ball
MelbourneBiotechnologyHealth CareTherapeuticsHealth Diagnostics

Description

Inoviq Ltd has appointed Dr. Emma Ball as Chief Commercial Officer, effective April 22, 2025. Dr Ball brings extensive experience from CSL Ltd and Illumina Inc, and will lead commercial efforts to advance INOVIQ’s technologies and products

Company Information

Company

Inoviq Ltd

Location

Melbourne, Victoria, Australia

About

INOVIQ Ltd is a biotechnology company focused on pioneering next-generation diagnostics and therapeutics for cancer. The company has commercialized its EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test for bladder cancer. INOVIQ is advancing diagnostics for ovarian and breast cancers and developing early-stage exosome therapeutics for solid tumors.

Predictive Intelligence
Strategic

ML-powered predictions for Inoviq Ltd's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.